Literature DB >> 25657108

Celastrol induces mitochondria-mediated apoptosis in hepatocellular carcinoma Bel-7402 cells.

Pei-Pei Li1, Wei He, Ping-Fan Yuan, Sha-Sha Song, Jing-Tao Lu, Wei Wei.   

Abstract

Celastrol is a natural terpenoid isolated from Tripterygium wilfordii, a well-known Chinese medicinal herb that presents anti-proliferative activities in several cancer cell lines. Here, we investigated whether celastrol induces apoptosis on hepatocellular carcinoma Bel-7402 cells and further explored the underlying molecular mechanisms. Celastrol caused a dose- and time-dependent growth inhibition and apoptosis of Bel-7402 cells. It increased apoptosis through the up-regulation of Bax and the down-regulation of Bcl-2 in Bel-7402 cells. Moreover, celastrol induced the release of cytochrome c and increased the activation of caspase-3 and caspase-9, suggesting that celastrol-induced apoptosis was related to the mitochondrial pathway. These results indicated that celastrol could induce apoptosis in Bel-7402 cells, which may be associated with the activation of the mitochondria-mediated pathway.

Entities:  

Keywords:  Apoptosis; Celastrol; Mitochondria-mediated pathway

Mesh:

Substances:

Year:  2015        PMID: 25657108     DOI: 10.1142/S0192415X15500093

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  11 in total

1.  Celastrol-induced apoptosis in human nasopharyngeal carcinoma is associated with the activation of the death receptor and the mitochondrial pathway.

Authors:  Heng-Fu Lin; Ming-Ju Hsieh; Yi-Ting Hsi; Yu-Sheng Lo; Yi-Ching Chuang; Mu-Kuan Chen; Su-Yu Chien
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

2.  Celastrol negatively regulates cell invasion and migration ability of human osteosarcoma via downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro.

Authors:  Xiaolong Yu; Qiang Wang; Xin Zhou; Changlin Fu; Ming Cheng; Runsheng Guo; Hucheng Liu; Bin Zhang; Min Dai
Journal:  Oncol Lett       Date:  2016-08-26       Impact factor: 2.967

3.  Celastrol protects TGF-β1-induced endothelial-mesenchymal transition.

Authors:  Fei Gong; Fang Zhao; Xue-Dong Gan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-04-11

4.  Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells.

Authors:  Zhongye Wang; Zhenyuan Zhai; Xiulan Du
Journal:  Exp Ther Med       Date:  2017-06-08       Impact factor: 2.447

5.  Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway.

Authors:  Xiaolong Yu; Xin Zhou; Changlin Fu; Qiang Wang; Tao Nie; Fan Zou; Runsheng Guo; Hucheng Liu; Bin Zhang; Min Dai
Journal:  Oncol Rep       Date:  2015-07-13       Impact factor: 3.906

6.  Protective Effects of Celastrol on Diabetic Liver Injury via TLR4/MyD88/NF-κB Signaling Pathway in Type 2 Diabetic Rats.

Authors:  Li-Ping Han; Chun-Jun Li; Bei Sun; Yun Xie; Yue Guan; Ze-Jun Ma; Li-Ming Chen
Journal:  J Diabetes Res       Date:  2016-01-19       Impact factor: 4.011

Review 7.  Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases.

Authors:  Rita Cascão; João E Fonseca; Luis F Moita
Journal:  Front Med (Lausanne)       Date:  2017-06-15

8.  Effects of diclofenac on the pharmacokinetics of celastrol in rats and its transport.

Authors:  Zengfu Wang; Dali Chen; Zhongwei Wang
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

9.  Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3/miR-223-3p/CXCR4 Axis.

Authors:  Hailong Si; Huiling Wang; Haijuan Xiao; Yu Fang; Zhaoli Wu
Journal:  Cancer Manag Res       Date:  2021-02-05       Impact factor: 3.989

Review 10.  Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer.

Authors:  Yannan Zheng; Wenhui Zhang; Lin Xu; Hua Zhou; Man Yuan; Hongxi Xu
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.